Will Twitter's Card Technology Allow Pharma Brands to Post FDA-Compliant Promotional Tweets?

In today's Pharma Marketing News, I reviewed three "workarounds" that might allow pharma marketers to post promotional tweets that satisfy FDA's recently published (18 June 2014) guidelines:Chain of TweetsTweets with Images (see "A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance")Twitter CardsRead "FDA Sets Up a Roadblock for Branded Rx Promotional Tweets" for the details regarding the first two options.Spoiler Alert: They both probably won't pass muster with the FDA.What about Twitter Cards?A little Twitter bird told me that Twitter Cards, which allow your tweets to go beyond basic text, are the best way for pharma marketers to work around FDA’s new guidelines. Brands can create a media-rich experience through images, product info, videos, etc. There are several types of Twitter cards. One type -- Summary Cards -- gives you 200 extra characters besides the tweet itself. For most drugs, this is probably enough room to include all the desired benefit information, plus the FDA-required important safety information (ISI) and link to full ISI.There's only ONE problem with Twitter Cards and it's a BIG one as far as promotional Rx drug tweets are concerned. That problem can be summed up in ONE word:Read more »
Source: Pharma Marketing Blog - Category: Pharma Commentators Tags: #fdasm Guidance Mobile Mobile Advertising social media Twitter Source Type: blogs